Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs11813268
rs11813268
0.010 GeneticVariation BEFREE We confirm the six known RCC risk loci and identify seven new loci at 1p32.3 (rs4381241, P=3.1 × 10<sup>-10</sup>), 3p22.1 (rs67311347, P=2.5 × 10<sup>-8</sup>), 3q26.2 (rs10936602, P=8.8 × 10<sup>-9</sup>), 8p21.3 (rs2241261, P=5.8 × 10<sup>-9</sup>), 10q24.33-q25.1 (rs11813268, P=3.9 × 10<sup>-8</sup>), 11q22.3 (rs74911261, P=2.1 × 10<sup>-10</sup>) and 14q24.2 (rs4903064, P=2.2 × 10<sup>-24</sup>). 28598434

2017

dbSNP: rs132793
rs132793
0.010 GeneticVariation BEFREE Sensitivity analyses were also performed.The rs2267437 polymorphism was associated with a significant increase in risks of overall cancers, breast cancer, renal cell carcinoma and hepatocellular carcinoma, and it could increase the cancer risk in Asian population; the rs5751129 polymorphism could increase the cancer risk in overall cancers; the rs132770 polymorphism was associated with the increased renal cell carcinoma risk; furthermore, the rs132793 polymorphism could decrease breast cancer risk and increase risks in "other cancers".Overall, the results provided evidences that the single nucleotide polymorphisms in XRCC6 promoter region might play different roles in various cancers, indicating different cancers have different tumorigenesis mechanisms. 25569644

2015

dbSNP: rs1417080
rs1417080
0.010 GeneticVariation BEFREE In this study, a 2-stage case-control study was performed to evaluate the association between 2 tagging SNPs (rs1417080 and rs7859384) and RCC susceptibility. 31038847

2019

dbSNP: rs3118523
rs3118523
0.010 GeneticVariation BEFREE Across RXRA, one haplotype located 3' of the coding sequence (rs748964, rs3118523), increased RCC risk 35% among individuals with the variant haplotype compared to those with the most common haplotype. 19753122

2009

dbSNP: rs6466135
rs6466135
0.010 GeneticVariation BEFREE In a three-phase design with a total of 2657 RCC cases and 5315 healthy controls, two single nucleotide polymorphisms (SNPs) that map to PIK3CG (rs6466135:A, ORmeta = 0.85, 95% CI = 0.77-0.94, Pmeta = 1.4 × 10-3) and ATM (rs611646:T, ORmeta = 1.17, 95% CI = 1.05-1.31, Pmeta = 3.5 × 10-3) were significantly associated with RCC risk. 29635281

2018

dbSNP: rs7132434
rs7132434
0.010 GeneticVariation BEFREE We conclude that the RCC risk allele at 12p12.1 maps to rs7132434, a functional variant in an enhancer that upregulates BHLHE41 expression which, in turn, induces IL-11, a member of the IL-6 cytokine family. 27384883

2016

dbSNP: rs748964
rs748964
0.010 GeneticVariation BEFREE Across RXRA, one haplotype located 3' of the coding sequence (rs748964, rs3118523), increased RCC risk 35% among individuals with the variant haplotype compared to those with the most common haplotype. 19753122

2009

dbSNP: rs7859384
rs7859384
0.010 GeneticVariation BEFREE This study suggests that rs7859384 of lncARSR was associated with RCC susceptibility and may act as a prognostic biomarker for patients with RCC. 31038847

2019

dbSNP: rs2231142
rs2231142
0.010 GeneticVariation BEFREE Carriers with the C/C genotype of the BCRP C421A polymorphism are at risk of developing nonpapillary RCC. 15906349

2005

dbSNP: rs1154454
rs1154454
0.010 GeneticVariation BEFREE We observed effect modification by variation in rs1154454 (ADH7) (p<sub>interaction</sub>  = 0.007); a per unit increase in alcohol drink/day was associated with 35% lower RCC risk among non-minor allele carriers, a 27% lower risk among those who carry one copy of the minor allele, but no association was observed among those with two copies of the minor allele. 29023769

2018

dbSNP: rs182052
rs182052
0.020 GeneticVariation BEFREE These results suggest that ADIPOQ rs182052 is significantly associated with cc</span>RCC risk. 25827778

2015

dbSNP: rs182052
rs182052
0.020 GeneticVariation BEFREE The present study found significant combined effects of obesity and the ADIPOQ rs182052 G/A+A/A genotype on the arsenic-related risk of RCC in a population with low arsenic exposure. 29723618

2018

dbSNP: rs266729
rs266729
0.010 GeneticVariation BEFREE In this case-control study, we examined the frequency of single nucleotide polymorphisms (rs182052G>A, rs266729C>G, and rs3774262G>A) in the adiponectin gene (ADIPOQ) in 1004 patients with clear cell renal cell carcinoma (ccRCC) compared with a group of healthy subjects (n = 1108). 25827778

2015

dbSNP: rs3774262
rs3774262
0.010 GeneticVariation BEFREE In this case-control study, we examined the frequency of single nucleotide polymorphisms (rs182052G>A, rs266729C>G, and rs3774262G>A) in the adiponectin gene (ADIPOQ) in 1004 patients with clear cell renal cell carcinoma (ccRCC) compared with a group of healthy subjects (n = 1108). 25827778

2015

dbSNP: rs1800435
rs1800435
0.010 GeneticVariation BEFREE No significant modification in RCC risk was observed for the functional variant rs1800435(K68N). 21799727

2011

dbSNP: rs2761016
rs2761016
0.010 GeneticVariation BEFREE Joint effects of lead and ALAD rs2761016 suggest an increased RCC risk for the homozygous wild-type and heterozygous alleles ((GG)OR = 2.68, 95%CI = 1.17-6.12, p = 0.01; (GA)OR = 1.79, 95%CI = 1.06-3.04 with an interaction approaching significance (p(int) = 0.06). 21799727

2011

dbSNP: rs1048798213
rs1048798213
APC
0.010 GeneticVariation BEFREE PBRM1 p.L641V was detected in the plasma sample of the ccRCC patient with an allele frequency of 0.2%. 30986100

2019

dbSNP: rs1442780982
rs1442780982
APC
0.010 GeneticVariation BEFREE PBRM1 p.L641V was detected in the plasma sample of the ccRCC patient with an allele frequency of 0.2%. 30986100

2019

dbSNP: rs1130409
rs1130409
0.010 GeneticVariation BEFREE In a case-control study of 612 RCC patients and 632 age and sex matched healthy controls, we genotyped two APE1 functional polymorphisms (-656 T>G, rs1760944 and 1349 T>G, rs1130409) and assessed their associations with risk of RCC. 21538578

2011

dbSNP: rs1760944
rs1760944
0.010 GeneticVariation BEFREE In a case-control study of 612 RCC patients and 632 age and sex matched healthy controls, we genotyped two APE1 functional polymorphisms (-656 T>G, rs1760944 and 1349 T>G, rs1130409) and assessed their associations with risk of RCC. 21538578

2011

dbSNP: rs405509
rs405509
0.010 GeneticVariation BEFREE The study was designed to explore the association of renal cell carcinoma (RCC) with VHL (rs779805), MTHFR (rs1801133) and APOE (rs8106822 and rs405509) polymorphisms, investigate the interactions among the single nucleotide polymorphisms (SNPs), and explore roles of the interactions in the pathogenesis of RCC in Chinese Han population. 26191297

2015

dbSNP: rs2606736
rs2606736
0.010 GeneticVariation BEFREE This study indicated that ATG7 polymorphisms (rs2606736 and rs6442260) have a protective role for ccRCC risk. 30827239

2019

dbSNP: rs6442260
rs6442260
0.010 GeneticVariation BEFREE This study indicated that ATG7 polymorphisms (rs2606736 and rs6442260) have a protective role for ccRCC risk. 30827239

2019

dbSNP: rs611646
rs611646
ATM
0.010 GeneticVariation BEFREE In a three-phase design with a total of 2657 RCC cases and 5315 healthy controls, two single nucleotide polymorphisms (SNPs) that map to PIK3CG (rs6466135:A, ORmeta = 0.85, 95% CI = 0.77-0.94, Pmeta = 1.4 × 10-3) and ATM (rs611646:T, ORmeta = 1.17, 95% CI = 1.05-1.31, Pmeta = 3.5 × 10-3) were significantly associated with RCC risk. 29635281

2018

dbSNP: rs750597831
rs750597831
ATM
0.010 GeneticVariation BEFREE The risk relevance of the P81S von Hippel-Lindau (VHL) gene hotspot mutation identified in clear cell renal cell carcinoma from individuals exposed occupationally to trichloroethylene (TCE) is not known. 23990666

2013